The health technology is being developed rapidly, and the investment in the national research and development is being grown continuously. However, the evidence-generation activity is not fulfilling its demand virtually. Because of this, the promising health technology is sometimes not introduced to clinical practice because of the lack of evidence. The gap in the introduction of promising health technology to the clinical site due to such lack of evidence can be sufficiently complemented through the strategic support of evidence-generation on national level. As such, this research aims to suggest the alternative of domestic evidence-generation support system, covering the health technology life cycle.